Arcadia Biosciences (RKDA) Stock Statistics & Valuation Metrics

Arcadia Biosciences has a market cap or net worth of $4.37M. The enterprise value is $3.99M.

Arcadia Biosciences has 1.37M shares outstanding. The number of shares has decreased by -2.65% in one year.

Arcadia Biosciences’s return on equity (ROE) is -1.13 and return on invested capital (ROIC) is -32.78%.

The current PE Ratio of Arcadia Biosciences is -1.15. Arcadia Biosciences’s PEG ratio is 0.02.

In the last 12 months, Arcadia Biosciences had revenue of $5.27M and earned -$5.83M in profits. Earnings per share was -$4.40.

In the last 12 months, operating cash flow was -$11.56M and capital expenditures -$68.00K, giving a free cash flow of -$11.63M billion.

Arcadia Biosciences pays an annual dividend of , resulting in a dividend yield of

Arcadia Biosciences upcoming earnings date is May 8, 2025, After Close.

Arcadia Biosciences as a current ratio of 3.61, with Debt / Equity ratio of 0.02

In the past 12 months, Arcadia Biosciences has paid $621.72K in taxes.

Arcadia Biosciences EV to EBITDA ratio is -1.09, with an EV/FCF ratio of -0.41.

Arcadia Biosciences has $6.58M in cash and marketable securities with $346.00K in debt, giving a net cash position of -$6.23M billion.

Gross margin is 41.27%, with operating margin of -72.31%, and net profit margin of -139.50%.

The average price target for Arcadia Biosciences is $12.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy